EUVIMEDEUVIMED entdecken
Fallbericht

Orbital Solitary Fibrous Tumor in a Commercial Airline Pilot

Munise Altinbas, Ayse Ozpınar, Müslime Akbaba, Senay A Nacaroglu, Mohammad Sargolzaeimoghaddam, Maral Sargolzaeimoghaddam

Aerospace Medicine and Human Performance · 2024

DOI: 10.3357/amhp.6385.2024 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Aerospace Medicine and Human Performance, 2024. Verfasst von Munise Altinbas und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Solitary Fibrous Tumors, Orbital Neoplasms, Aerospace Medicine, Pilots. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In the literature, central serous retinopathy (CSR) accompanying solitary fibrous tumors (SFT) in a pilot has not been reported. In airline pilots, mass effect-related symptoms such as diplopia, ptosis, etc., seen with orbital tumors may endanger flight safety. CASE REPORT: A 62-yr-old male commercial airline pilot presented with blurred vision in the right eye. He had been receiving treatment for 2 mo because of CSR. His visual acuity was 10/20 in the right eye and 20/20 in the left. During examination, ptosis and exophthalmos were noticed in the right eye. Ocular movements were free in all cardinal directions and there was downward displacement in the right eye. There was no diplopia. Magnetic resonance imaging revealed a 1.5- to 2-cm well-defined contrast-enhancing mass in the lateral extraconal orbit. His medical flight certificate was suspended for 3 mo due to decreased visual acuity and superior visual defect. Superior orbitotomy was performed without any complication. Ptosis and CSR had regressed 1 wk after surgery. All systemic and ophthalmological examinations met aviation medical certificate requirements. He returned to flight on the condition of being checked every 3 mo. At the 1-yr follow-up, there was no sign of recurrences of SFT or CSR. DISCUSSION: SFTs are slow-growing neoplasms that can manifest symptoms related to mass effect. In the current literature, there are no reported cases of the coexistence of orbital SFT and CSR or pilots able to resume flight duties only 1 wk after a successful orbitotomy and tumor resection surgery. Altinbas M, Ozpınar A, Akbaba M, Nacaroglu SA, Sargolzaeimoghaddam M, Sargolzaeimoghaddam M. Orbital solitary fibrous tumor in a commercial airline pilot . Aerosp Med Hum Perform. 2024; 95(6):333–336.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Solitary Fibrous TumorsOrbital NeoplasmsAerospace MedicinePilotsMagnetic Resonance ImagingHumansMaleMiddle AgedVisual AcuityVision Disorders

Zitieren

APA

Altinbas, M., Ozpınar, A., Akbaba, M., Nacaroglu, S. A., Sargolzaeimoghaddam, M., & Sargolzaeimoghaddam, M. (2024). Orbital Solitary Fibrous Tumor in a Commercial Airline Pilot. Aerospace Medicine and Human Performance. https://doi.org/10.3357/amhp.6385.2024

Vancouver

Altinbas M, Ozpınar A, Akbaba M, Nacaroglu SA, Sargolzaeimoghaddam M, Sargolzaeimoghaddam M. Orbital Solitary Fibrous Tumor in a Commercial Airline Pilot. Aerospace Medicine and Human Performance. 2024. doi:10.3357/amhp.6385.2024

BibTeX
@article{Altinbas2024,
  author = {Altinbas, Munise and Ozpınar, Ayse and Akbaba, Müslime and Nacaroglu, Senay A and Sargolzaeimoghaddam, Mohammad and Sargolzaeimoghaddam, Maral},
  title = {Orbital Solitary Fibrous Tumor in a Commercial Airline Pilot},
  journal = {Aerospace Medicine and Human Performance},
  year = {2024},
  doi = {10.3357/amhp.6385.2024}
}
Kostenlos starten →